Clinical Trials Directory

Trials / Unknown

UnknownNCT01274923

Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction in PDE5i Responders

The Effect of Low Intensity Shock Wave Therapy on Erectile Dysfunction in Patients Responding to PDE5i's

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
Male
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the effect of shockwave therapy on erectile dysfunction on patients responding to PDE5i therapy in a sham controlled randomized double blind manner.

Detailed description

This study aims to evaluate the effect of a 12-session low intensity shockwave therapy protocol for patients with erectile dysfunction. On screening patients will undergo evaluation by thorough medical history and by questionnaires for evaluation of sexual function. A one-month active treatment with PDE5i will be provided followed by re-evaluation using the same questionnaires. Then another one-month period without PDE5i medication (washout period ) will be done and finally on the following visit evaluation will include the same questionnaires and if fit for inclusion- additional objective evaluation of endothelial function using the Flow mediated dilatation technique and penile blood flow measurement by doppler ultrasound of the Penis will be performed. At the end of this screening pahse the first shock wave session will be performed. Altogether 12 treatment sessions will be performed - 6 treatments twice a week followed by a 3 week no-treatment interval and again 6 treatments twice a week. Follow-up which will include the same evaluation as in the first treatment visit will be performed one month after end of treatment

Conditions

Interventions

TypeNameDescription
DEVICE"MEDISPEC" treatment probeshock wave treatment

Timeline

Start date
2010-08-01
Primary completion
2012-08-01
Completion
2012-10-01
First posted
2011-01-12
Last updated
2011-05-18

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01274923. Inclusion in this directory is not an endorsement.